Kaveri Pohlman
Stock Analyst at Clear Street
(2.83)
# 2,008
Out of 5,113 analysts
34
Total ratings
35.48%
Success rate
3.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPT RAPT Therapeutics | Downgrades: Hold | $60 → $58 | $57.61 | +0.68% | 3 | Jan 20, 2026 | |
| JANX Janux Therapeutics | Downgrades: Hold | $32 → $12 | $14.73 | -18.53% | 3 | Jan 20, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $12 | $1.81 | +562.98% | 1 | Dec 30, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $61 → $99 | $89.51 | +10.60% | 1 | Dec 9, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $200 | $83.97 | +138.18% | 1 | Dec 5, 2025 | |
| JBIO Jade Biosciences | Initiates: Buy | $25 | $16.05 | +55.76% | 1 | Nov 25, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $11 → $21 | $10.96 | +91.61% | 1 | Nov 14, 2025 | |
| ZURA Zura Bio | Initiates: Buy | $18 | $6.43 | +179.94% | 1 | Nov 13, 2025 | |
| SGMT Sagimet Biosciences | Initiates: Buy | $29 | $6.09 | +376.19% | 1 | Oct 22, 2025 | |
| VTYX Ventyx Biosciences | Initiates: Buy | $11 | $13.99 | -21.37% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 | $34.90 | +31.81% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $23.10 | +38.53% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.84 | - | 4 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $47 | $34.40 | +36.63% | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $30 | $12.34 | +143.11% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $38 | $13.17 | +188.53% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $5.61 | -10.87% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $1.64 | +387.80% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $43.74 | -38.27% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $22.99 | +204.48% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.02 | +198.51% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $5.93 | +34.91% | 2 | Jul 7, 2022 |
RAPT Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: $60 → $58
Current: $57.61
Upside: +0.68%
Janux Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: $32 → $12
Current: $14.73
Upside: -18.53%
Palisade Bio
Dec 30, 2025
Initiates: Buy
Price Target: $12
Current: $1.81
Upside: +562.98%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $61 → $99
Current: $89.51
Upside: +10.60%
Palvella Therapeutics
Dec 5, 2025
Initiates: Buy
Price Target: $200
Current: $83.97
Upside: +138.18%
Jade Biosciences
Nov 25, 2025
Initiates: Buy
Price Target: $25
Current: $16.05
Upside: +55.76%
Trevi Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $11 → $21
Current: $10.96
Upside: +91.61%
Zura Bio
Nov 13, 2025
Initiates: Buy
Price Target: $18
Current: $6.43
Upside: +179.94%
Sagimet Biosciences
Oct 22, 2025
Initiates: Buy
Price Target: $29
Current: $6.09
Upside: +376.19%
Ventyx Biosciences
Oct 1, 2025
Initiates: Buy
Price Target: $11
Current: $13.99
Upside: -21.37%
Sep 17, 2025
Maintains: Buy
Price Target: $46
Current: $34.90
Upside: +31.81%
Jun 25, 2025
Initiates: Buy
Price Target: $32
Current: $23.10
Upside: +38.53%
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.84
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $34.40
Upside: +36.63%
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $12.34
Upside: +143.11%
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $13.17
Upside: +188.53%
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $5.61
Upside: -10.87%
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.64
Upside: +387.80%
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $43.74
Upside: -38.27%
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $22.99
Upside: +204.48%
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $4.02
Upside: +198.51%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $5.93
Upside: +34.91%